ID

22026

Description

Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase; ODM derived from: https://clinicaltrials.gov/show/NCT00324077

Lien

https://clinicaltrials.gov/show/NCT00324077

Mots-clés

Versions (2)
  1. 15/05/2017 15/05/2017 -
  2. 15/05/2017 15/05/2017 -
Téléchargé le

15 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Myeloid Leukemia, Chronic, Chronic-Phase NCT00324077

Anglais

Eligibility Myeloid Leukemia, Chronic, Chronic-Phase NCT00324077

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females, 18 or older
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
chronic phase ph+ or bcr-abl positive cml
Description

Chronic-Phase Myeloid Leukemia Philadelphia chromosome positive | Chronic myelogenous leukemia, BCR/ABL positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023474
UMLS CUI [1,2]
C0856536
UMLS CUI [2]
C1292771
current complete hematologic response to imatinib
Description

imatinib | Complete Hematologic Response

Type de données

boolean

Alias
UMLS CUI [1]
C0935989
UMLS CUI [2]
C4050175
lack of major molecular response
Description

Molecular Major Response Lacking

Type de données

boolean

Alias
UMLS CUI [1,1]
C4049637
UMLS CUI [1,2]
C0332268
on imatinib for at least one year
Description

imatinib Duration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0935989
UMLS CUI [1,2]
C0449238
on the same imatinib dose for at least 6 months
Description

imatinib Dose Same Duration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0935989
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0445247
UMLS CUI [1,4]
C0449238
adequate hepatic and renal function
Description

Liver function | Renal function

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of accelerated or blast phase cml
Description

Leukemia, Myeloid, Accelerated Phase | Blast Phase

Type de données

boolean

Alias
UMLS CUI [1]
C0023472
UMLS CUI [2]
C0005699
serious uncontrolled medical disorder or active infection
Description

Disease Uncontrolled Serious | Communicable Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0205404
UMLS CUI [2]
C0009450
significant cardiovascular disease or bleeding disorder
Description

Cardiovascular Disease | Blood Coagulation Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0005779
concurrent use of medications at risk of causing torsades de pointe
Description

Pharmaceutical Preparations At risk Causing Torsades de points

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C0678227
UMLS CUI [1,4]
C3842160
Retour au début de la page

Similar models

Eligibility Myeloid Leukemia, Chronic, Chronic-Phase NCT00324077

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
males and females, 18 or older
boolean
C0001779 (UMLS CUI [1])
Chronic-Phase Myeloid Leukemia Philadelphia chromosome positive | Chronic myelogenous leukemia, BCR/ABL positive
Item
chronic phase ph+ or bcr-abl positive cml
boolean
C0023474 (UMLS CUI [1,1])
C0856536 (UMLS CUI [1,2])
C1292771 (UMLS CUI [2])
imatinib | Complete Hematologic Response
Item
current complete hematologic response to imatinib
boolean
C0935989 (UMLS CUI [1])
C4050175 (UMLS CUI [2])
Molecular Major Response Lacking
Item
lack of major molecular response
boolean
C4049637 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
imatinib Duration
Item
on imatinib for at least one year
boolean
C0935989 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
imatinib Dose Same Duration
Item
on the same imatinib dose for at least 6 months
boolean
C0935989 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0445247 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
Liver function | Renal function
Item
adequate hepatic and renal function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Leukemia, Myeloid, Accelerated Phase | Blast Phase
Item
history of accelerated or blast phase cml
boolean
C0023472 (UMLS CUI [1])
C0005699 (UMLS CUI [2])
Disease Uncontrolled Serious | Communicable Disease
Item
serious uncontrolled medical disorder or active infection
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2])
Cardiovascular Disease | Blood Coagulation Disorder
Item
significant cardiovascular disease or bleeding disorder
boolean
C0007222 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Pharmaceutical Preparations At risk Causing Torsades de points
Item
concurrent use of medications at risk of causing torsades de pointe
boolean
C0013227 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0678227 (UMLS CUI [1,3])
C3842160 (UMLS CUI [1,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial